Pages that link to "Q40498918"
Jump to navigation
Jump to search
The following pages link to Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms (Q40498918):
Displaying 48 items.
- Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter (Q24548405) (← links)
- Epigenomics of leukemia: from mechanisms to therapeutic applications (Q26823403) (← links)
- Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells (Q28080022) (← links)
- ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma (Q33519164) (← links)
- The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines (Q33651543) (← links)
- 5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis (Q33665187) (← links)
- Comprehensive mapping of the effects of azacitidine on DNA methylation, repressive/permissive histone marks and gene expression in primary cells from patients with MDS and MDS-related disease (Q33709905) (← links)
- HSPC117 is regulated by epigenetic modification and is involved in the migration of JEG-3 cells (Q33907925) (← links)
- Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies (Q33980682) (← links)
- Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis (Q34090091) (← links)
- Osteopontin regulates human glioma cell invasiveness and tumor growth in mice (Q34132676) (← links)
- Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation (Q34305840) (← links)
- 5-aza-2'-deoxycytidine leads to reduced embryo implantation and reduced expression of DNA methyltransferases and essential endometrial genes (Q34428877) (← links)
- Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies (Q35136616) (← links)
- 5-aza-2'-deoxycytidine activates iron uptake and heme biosynthesis by increasing c-Myc nuclear localization and binding to the E-boxes of transferrin receptor 1 (TfR1) and ferrochelatase (Fech) genes. (Q35423470) (← links)
- A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy (Q35794439) (← links)
- Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis (Q35903837) (← links)
- Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation (Q36082658) (← links)
- Regulation of MT1-MMP/MMP-2/TIMP-2 axis in human placenta (Q36140125) (← links)
- Genomic impact of transient low-dose decitabine treatment on primary AML cells (Q36654140) (← links)
- SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression (Q36663265) (← links)
- Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines (Q37066258) (← links)
- High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines (Q37655865) (← links)
- DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML (Q38947913) (← links)
- Quantitative determination of decitabine incorporation into DNA and its effect on mutation rates in human cancer cells (Q38962596) (← links)
- Decitabine induces delayed reactive oxygen species (ROS) accumulation in leukemia cells and induces the expression of ROS generating enzymes (Q38971726) (← links)
- Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B. (Q39031283) (← links)
- Cell type-specific activation of the cytomegalovirus promoter by dimethylsulfoxide and 5-aza-2'-deoxycytidine (Q39281623) (← links)
- The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria‐mediated apoptosis and DNA damage in p53 mutant leukemic T cells (Q39566623) (← links)
- Frequent methylation of RASSF1A in synovial sarcoma and the anti-tumor effects of 5-aza-2'-deoxycytidine against synovial sarcoma cell lines (Q39828946) (← links)
- Additive effects of 5-aza-2'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines (Q39851827) (← links)
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells (Q39887368) (← links)
- p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia (Q39916396) (← links)
- p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage. (Q40020060) (← links)
- DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. (Q40054309) (← links)
- Discovery of epigenetically silenced genes in acute myeloid leukemias (Q40165138) (← links)
- Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation (Q40396552) (← links)
- Azacitidine induces profound genome-wide hypomethylation in primary myelodysplastic bone marrow cultures but may also reduce histone acetylation (Q43577534) (← links)
- Molecular modeling and molecular dynamics studies of hydralazine with human DNA methyltransferase 1. (Q46074208) (← links)
- Drug therapy for myelodysplastic syndrome: building evidence for action (Q46987622) (← links)
- DNA methylation regulated microRNAs in HPV-16-induced head and neck squamous cell carcinoma (HNSCC). (Q49890881) (← links)
- DNA protein crosslink proteolysis repair: From yeast to premature ageing and cancer in humans (Q58701163) (← links)
- Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes (Q80455361) (← links)
- Decitabine: in myelodysplastic syndromes (Q83892610) (← links)
- Epigenetic Modification of CFTR in Head and Neck Cancer (Q90394856) (← links)
- Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML (Q90406673) (← links)
- Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation (Q93336703) (← links)
- LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia (Q98943915) (← links)